Faruqi & Faruqi Investigates Semler Scientific Securities Lawsuit

Faruqi & Faruqi LLP is investigating potential claims against Semler Scientific, a biotech company, for alleged securities fraud. Investors who purchased or acquired Semler Scientific securities between March 10, 2021, and April 15, 2025, may be eligible to seek lead plaintiff status in a federal securities class action. The deadline to do so is October 28, 2025. Those interested can contact Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) or click the link provided for additional information.

Investors in Semler Scientific Inc. (NASDAQ: SMLR) may have a legal recourse against the biotech company following recent revelations. Faruqi & Faruqi LLP, a leading securities fraud law firm, is investigating potential claims against Semler Scientific for alleged securities fraud. The firm is encouraging investors who purchased or acquired Semler Scientific securities between March 10, 2021, and April 15, 2025, to seek lead plaintiff status in a federal securities class action.

The deadline to do so is October 28, 2025. Those interested can contact Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) or click the link provided for additional information.

Semler Scientific faced scrutiny when it disclosed in February 2025 that there was a risk of a civil False Claims Act lawsuit by the U.S. Department of Justice (DOJ) regarding its QuantaFlo device. The company's stock price fell by 9.4% on this news. Later, on April 15, 2025, Semler Scientific announced a settlement agreement with the DOJ for $29.75 million, which further impacted the stock price [1].

The class action lawsuit alleges that Semler Scientific made materially false and misleading statements during the Class Period, failing to disclose a material investigation by the DOJ into violations of the False Claims Act. This led to investors suffering damages when the true details entered the market [2][3].

Investors are urged to act promptly to protect their rights. Faruqi & Faruqi LLP has a proven track record in representing investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide.

References:
[1] https://www.morningstar.com/news/business-wire/20250903792103/glancy-prongay-murray-llp-a-leading-securities-fraud-law-firm-encourages-semler-scientific-inc-smlr-investors-to-inquire-about-securities-fraud-class-action
[2] https://www.morningstar.com/news/globe-newswire/9521771/smlr-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-semler-scientific-inc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit
[3] https://www.morningstar.com/news/globe-newswire/9524494/rosen-the-first-filing-firm-encourages-semler-scientific-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-commenced-by-the-firm-smlr